Merck & Co Inc (NYSE:MRK)
| 88.72 Delayed Data As of 6:30pm ET |  -0.13 / -0.15%Today’s Change | 70.89 Today|||52-Week Range 89.24 | +16.11% Year-to-Date |
MRK Regular Dividend: MRK will begin trading ex-dividend on 12/13/19 with a $0.61 dividend payable to shareholders of record as of 12/16/19.
Latest MRK News | Press Releases
| What Happened in the Stock Market Today 5:05pm / MotleyFool.com - Paid Partner Content | Is Clovis Oncology Really a Buyout Candidate? Dec 03 / MotleyFool.com - Paid Partner Content |
| Why ArQule Shares Are Skyrocketing Today 11:19am / MotleyFool.com - Paid Partner Content | 3 Top Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content |
| Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors Dec 03 / MotleyFool.com - Paid Partner Content | Here's Why Lexicon Pharmaceuticals Is Tumbling Today Dec 02 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 88.85 |
| Today’s open | 88.90 |
| Day’s range | 88.20 - 89.00 |
| Volume | 7,730,032 |
| Average volume (3 months) | 8,322,217 |
| Market cap | $226.2B |
Data as of 6:30pm ET, 12/09/2019
Growth & Valuation
| Earnings growth (last year) | +165.32% |
| Earnings growth (this year) | +18.79% |
| Earnings growth (next 5 years) | +8.90% |
| Revenue growth (last year) | +6.17% |
| P/E ratio | 24.8 |
| Price/Sales | 4.82 |
| Price/Book | 8.63 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.03 | +0.08% |
| NVSNovartis | +0.46 | +0.50% |
| BMYBristol-Myers Squibb | +1.33 | +2.22% |
| ABBVAbbVie | -0.54 | -0.62% |
Data as of 6:30pm ET, 12/09/2019
Financials
| Next reporting date | February 5, 2020 |
| EPS forecast (this quarter) | $1.16 |
| Annual revenue (last year) | $42.4B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 14.65% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
